F16.951 Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder with hallucinations

Name of the Condition

• Hallucinogen Use, Unspecified with Hallucinogen-Induced Psychotic Disorder with Hallucinations
• Medical Term: ICD-10-CM F16.951

Summary

Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder with hallucinations refers to the use of hallucinogenic substances associated with the development of a psychotic disorder characterized by hallucinations. This code is applied when clinical documentation confirms hallucinogen exposure and the presence of psychotic symptoms, specifically hallucinations, without further specification of the use pattern. It encompasses cases where hallucinogen use is linked to persistent or transient hallucinatory experiences, distinct from other psychotic features like delusions alone.

Causes

Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder with hallucinations typically involves substances that alter perception, mood, or cognitive function, such as LSD, psilocybin, or mescaline. The psychotic disorder arises from the direct effects of the hallucinogen on the central nervous system, leading to hallucinatory symptoms. The documentation does not specify a problematic pattern beyond the association with the induced psychotic disorder with hallucinations.

Risk Factors

• Recreational or experimental use of hallucinogens
• Pre-existing mental health conditions (e.g., schizophrenia, bipolar disorder)
• Genetic predisposition to psychotic disorders
• High-dose or frequent hallucinogen use
• Co-occurring substance use disorders

Symptoms

• Auditory, visual, or tactile hallucinations (e.g., seeing or hearing things not present)
• Distorted sensory perceptions
• Altered sense of reality or time
• Mood changes (e.g., euphoria, anxiety, or paranoia)
• Impaired judgment or cognitive function

Diagnosis

Diagnosis requires clinical documentation confirming hallucinogen exposure and the presence of hallucinations as part of a psychotic disorder. Healthcare providers assess symptoms, substance use history, and ruling out other causes of psychosis (e.g., medical conditions or other substances). The code is used when the pattern of hallucinogen use is unspecified, and the psychotic disorder is directly attributed to hallucinogen use.

Treatment Options

Treatment focuses on managing acute symptoms and addressing underlying substance use. Interventions may include antipsychotic medications to reduce hallucinations, supportive care, and psychotherapy. Long-term management may involve substance use counseling, relapse prevention strategies, and monitoring for co-occurring mental health conditions.

Prognosis and Follow-Up

Prognosis varies based on the severity of symptoms, duration of use, and response to treatment. Some individuals may experience transient symptoms, while others may have persistent or recurrent episodes. Follow-up care is essential to monitor for symptom recurrence, adjust treatment, and address ongoing substance use or mental health needs.

Complications

• Persistent or chronic psychotic symptoms
• Worsening of pre-existing mental health conditions
• Impaired daily functioning (e.g., work, relationships)
• Increased risk of accidental injury or self-harm
• Co-occurring substance use disorders

Lifestyle & Prevention

• Avoiding hallucinogen use or limiting exposure to reduce risk
• Seeking early intervention for substance use concerns
• Building a support network (e.g., family, friends, or support groups)
• Engaging in stress-reduction techniques (e.g., mindfulness, exercise)
• Educating oneself about the risks of hallucinogen use

When to Seek Professional Help

Seek immediate medical attention if hallucinations are severe, persistent, or accompanied by self-harm, suicidal thoughts, or impaired judgment. Consult a healthcare provider for ongoing symptoms, difficulty managing substance use, or worsening mental health.

Tips for Medical Coders

Document the presence of hallucinations as part of the psychotic disorder and confirm hallucinogen use without specifying the pattern (e.g., abuse, dependence). Ensure clinical notes link the hallucinations directly to hallucinogen exposure. Use this code when the psychotic disorder is induced by hallucinogens and hallucinations are the primary symptom, with no further specification of use severity or pattern.